176 related articles for article (PubMed ID: 36868229)
1. PITX2 induction leads to impaired cardiomyocyte function in arrhythmogenic cardiomyopathy.
van Kampen SJ; Han SJ; van Ham WB; Kyriakopoulou E; Stouthart EW; Goversen B; Monshouwer-Kloots J; Perini I; de Ruiter H; van der Kraak P; Vink A; van Laake LW; Groeneweg JA; de Boer TP; Tsui H; Boogerd CJ; van Veen TAB; van Rooij E
Stem Cell Reports; 2023 Mar; 18(3):749-764. PubMed ID: 36868229
[TBL] [Abstract][Full Text] [Related]
2. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
3. Impact of the DSP-H1684R Genetic Variant on Ion Channels Activity in iPSC-Derived Cardiomyocytes.
Gusev K; Khudiakov A; Zaytseva A; Perepelina K; Makeenok S; Kaznacheyeva E; Kostareva A
Cell Physiol Biochem; 2020 Jul; 54(4):696-706. PubMed ID: 32706220
[TBL] [Abstract][Full Text] [Related]
4. Patient mutations linked to arrhythmogenic cardiomyopathy enhance calpain-mediated desmoplakin degradation.
Ng R; Manring H; Papoutsidakis N; Albertelli T; Tsai N; See CJ; Li X; Park J; Stevens TL; Bobbili PJ; Riaz M; Ren Y; Stoddard CE; Janssen PM; Bunch TJ; Hall SP; Lo YC; Jacoby DL; Qyang Y; Wright N; Ackermann MA; Campbell SG
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31194698
[TBL] [Abstract][Full Text] [Related]
5. Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model.
Lyon RC; Mezzano V; Wright AT; Pfeiffer E; Chuang J; Banares K; Castaneda A; Ouyang K; Cui L; Contu R; Gu Y; Evans SM; Omens JH; Peterson KL; McCulloch AD; Sheikh F
Hum Mol Genet; 2014 Mar; 23(5):1134-50. PubMed ID: 24108106
[TBL] [Abstract][Full Text] [Related]
6. Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis.
Te Riele AS; Agullo-Pascual E; James CA; Leo-Macias A; Cerrone M; Zhang M; Lin X; Lin B; Sobreira NL; Amat-Alarcon N; Marsman RF; Murray B; Tichnell C; van der Heijden JF; Dooijes D; van Veen TA; Tandri H; Fowler SJ; Hauer RN; Tomaselli G; van den Berg MP; Taylor MR; Brun F; Sinagra G; Wilde AA; Mestroni L; Bezzina CR; Calkins H; Peter van Tintelen J; Bu L; Delmar M; Judge DP
Cardiovasc Res; 2017 Jan; 113(1):102-111. PubMed ID: 28069705
[TBL] [Abstract][Full Text] [Related]
7. Silencing of desmoplakin decreases connexin43/Nav1.5 expression and sodium current in HL‑1 cardiomyocytes.
Zhang Q; Deng C; Rao F; Modi RM; Zhu J; Liu X; Mai L; Tan H; Yu X; Lin Q; Xiao D; Kuang S; Wu S
Mol Med Rep; 2013 Sep; 8(3):780-6. PubMed ID: 23877755
[TBL] [Abstract][Full Text] [Related]
8. Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells.
Asimaki A; Protonotarios A; James CA; Chelko SP; Tichnell C; Murray B; Tsatsopoulou A; Anastasakis A; te Riele A; Kléber AG; Judge DP; Calkins H; Saffitz JE
Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003688. PubMed ID: 26850880
[TBL] [Abstract][Full Text] [Related]
9. Desmoplakin maintains gap junctions by inhibiting Ras/MAPK and lysosomal degradation of connexin-43.
Kam CY; Dubash AD; Magistrati E; Polo S; Satchell KJF; Sheikh F; Lampe PD; Green KJ
J Cell Biol; 2018 Sep; 217(9):3219-3235. PubMed ID: 29959233
[TBL] [Abstract][Full Text] [Related]
10. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Yang Z; Bowles NE; Scherer SE; Taylor MD; Kearney DL; Ge S; Nadvoretskiy VV; DeFreitas G; Carabello B; Brandon LI; Godsel LM; Green KJ; Saffitz JE; Li H; Danieli GA; Calkins H; Marcus F; Towbin JA
Circ Res; 2006 Sep; 99(6):646-55. PubMed ID: 16917092
[TBL] [Abstract][Full Text] [Related]
11. Understanding Arrhythmogenic Cardiomyopathy: Advances through the Use of Human Pluripotent Stem Cell Models.
Chua CJ; Morrissette-McAlmon J; Tung L; Boheler KR
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895213
[TBL] [Abstract][Full Text] [Related]
12. Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy.
Tsui H; van Kampen SJ; Han SJ; Meraviglia V; van Ham WB; Casini S; van der Kraak P; Vink A; Yin X; Mayr M; Bossu A; Marchal GA; Monshouwer-Kloots J; Eding J; Versteeg D; de Ruiter H; Bezstarosti K; Groeneweg J; Klaasen SJ; van Laake LW; Demmers JAA; Kops GJPL; Mummery CL; van Veen TAB; Remme CA; Bellin M; van Rooij E
Sci Transl Med; 2023 Mar; 15(688):eadd4248. PubMed ID: 36947592
[TBL] [Abstract][Full Text] [Related]
13. Generation of human induced pluripotent stem cell line EURACi006-A and its isogenic gene-corrected line EURACi006-A-1 from an arrhythmogenic cardiomyopathy patient carrying the c.1643delG PKP2 mutation.
Meraviglia V; Ganesh S; Arendzen CH; Freund C; Sommariva E; Rossini A; Bellin M
Stem Cell Res; 2021 Jul; 54():102426. PubMed ID: 34134068
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cardiac myocyte cohesion and gap junctions via desmosomal adhesion.
Schinner C; Erber BM; Yeruva S; Waschke J
Acta Physiol (Oxf); 2019 Jun; 226(2):e13242. PubMed ID: 30582290
[TBL] [Abstract][Full Text] [Related]
15.
Schulz C; Lemoine MD; Mearini G; Koivumäki J; Sani J; Schwedhelm E; Kirchhof P; Ghalawinji A; Stoll M; Hansen A; Eschenhagen T; Christ T
Circ Arrhythm Electrophysiol; 2023 Mar; 16(3):e011602. PubMed ID: 36763906
[TBL] [Abstract][Full Text] [Related]
16. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
[TBL] [Abstract][Full Text] [Related]
17. Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutation.
Meraviglia V; Arendzen CH; Tok M; Freund C; Maione AS; Sommariva E; Bellin M
Stem Cell Res; 2020 Jul; 46():101835. PubMed ID: 32485643
[TBL] [Abstract][Full Text] [Related]
18. Modeling incomplete penetrance in arrhythmogenic cardiomyopathy by human induced pluripotent stem cell derived cardiomyocytes.
De Bortoli M; Meraviglia V; Mackova K; Frommelt LS; König E; Rainer J; Volani C; Benzoni P; Schlittler M; Cattelan G; Motta BM; Volpato C; Rauhe W; Barbuti A; Zacchigna S; Pramstaller PP; Rossini A
Comput Struct Biotechnol J; 2023; 21():1759-1773. PubMed ID: 36915380
[TBL] [Abstract][Full Text] [Related]
19. New insights into the molecular basis of desmoplakin- and desmin-related cardiomyopathies.
Lapouge K; Fontao L; Champliaud MF; Jaunin F; Frias MA; Favre B; Paulin D; Green KJ; Borradori L
J Cell Sci; 2006 Dec; 119(Pt 23):4974-85. PubMed ID: 17105773
[TBL] [Abstract][Full Text] [Related]
20. Missense Mutations in Desmoplakin Plakin Repeat Domains Have Dramatic Effects on Domain Structure and Function.
Mohammed F; Odintsova E; Chidgey M
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
